Literature DB >> 16227563

Ataxia, peripheral neuropathy, and anti-gliadin antibody. Guilt by association?

R J Lock1, D S N A Pengiran Tengah, D J Unsworth, J J Ward, A J Wills.   

Abstract

Some authors contend that patients with idiopathic neurological disease who are also anti-gliadin antibody seropositive are gluten sensitive. However, anti-gliadin antibodies lack disease specificity being found in 10% of healthy blood donors. We report a study comparing anti-gliadin antibody with other food antibodies in patients with idiopathic ataxia (20), hereditary ataxias (seven), or idiopathic peripheral neuropathy (32). Patients were HLA typed. IgA anti-tissue transglutaminase antibodies (tTG) were measured. No case was positive for IgA anti-tTG making occult coeliac disease unlikely. HLA DQ2 and HLA DQ8 were found distributed equally across all patient groups and unrelated to gliadin antibody status. HLA DQ2 expressing, anti-gliadin antibody positive cases (so called "gluten ataxia") were rare in our clinics (four cases in 2 years from a population of 2 million). We conclude that coeliac disease per se is not commonly associated with either idiopathic ataxia or idiopathic peripheral neuropathy. Our study also casts doubt on the nosological status of "gluten ataxia" as a discreet disease entity. All food antibodies tested, particularly IgG, were a common finding in both ataxia and peripheral neuropathy groups. No particular food antibody was associated with any patient group. Food antibodies were equally common in hereditary ataxias. We conclude they are a non-specific finding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227563      PMCID: PMC1739395          DOI: 10.1136/jnnp.2004.058487

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  5 in total

1.  The neurologic significance of celiac disease biomarkers.

Authors:  Andrew McKeon; Vanda A Lennon; Sean J Pittock; Thomas J Kryzer; Joseph Murray
Journal:  Neurology       Date:  2014-09-26       Impact factor: 9.910

2.  Clinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2011-07-01

3.  Serum antigliadin antibodies in cerebellar ataxias: a systematic review and meta-analysis.

Authors:  Chi-Ying Lin; Min-Jung Wang; Winona Tse; Rachel Pinotti; Armin Alaedini; Peter H R Green; Sheng-Han Kuo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-06-04       Impact factor: 10.154

4.  Antigliadin antibody in sporadic adult ataxia.

Authors:  Yaser Hamidian; Mansoureh Togha; Shahriar Nafisi; Shahab Dowlatshahi; Soodeh Razeghi Jahromi; Nahid Beladi Moghadam; Navid Namazi; Parvin Tajik; Masoud Majed; Mahdi Aloosh
Journal:  Iran J Neurol       Date:  2012

Review 5.  Neurological manifestations, diagnosis, and treatment of celiac disease: A comprehensive review.

Authors:  Shahriar Nikpour
Journal:  Iran J Neurol       Date:  2012
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.